Tecentriq (atezolizumab) - Roche
Tecentriq: Regulatory submissions in US/EU in combination with paclitaxel for 1L TNBC in 2020 (Roche) - Jan 30, 2020 - Regulatory submissions in US/EU in combination with nab-paclitaxel for adjuvant TNBC in 2020 
European regulatory • sBLA
http://roche.com/dam/jcr:6c0035b5-3447-4b2c-aeae-9649f5197ccb/en/irp200130.pdf
 
Jan 30, 2020
 
 
8e0cfe38-4370-4938-aef0-c41cfe28c549.jpg